We are live on ! Find out more
JHMH

John Hancock Multifactor Healthcare ETF

Delisted

JHMH was delisted on the 24th of October, 2022.

9 hedge funds and large institutions have $33.2M invested in John Hancock Multifactor Healthcare ETF in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $26.9M → $33.2M (+$6.26M)

0% more funds holding

Funds holding: 99 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
7
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

JHMH Hedge Fund Activity: Q3 2016 in Review

9 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q3 2016, worth a combined $33.2M — up 23% from $26.9M a quarter earlier.

Fund positioning in JHMH was balanced in Q3 2016: 1 fund opened new positions, 1 closed out, 7 added to existing stakes and 0 trimmed.

The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $4.51M. The largest seller was UBS Group, exiting entirely with an estimated $14K sold.

  • 9 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $33.2M of John Hancock Multifactor Healthcare ETF stock for Q3 2016, up 23% quarter-over-quarter.
  • 1 fund opened new John Hancock Multifactor Healthcare ETF positions in Q3 2016 and 1 closed out, a net change of 0 holders.
  • The largest John Hancock Multifactor Healthcare ETF buyer in Q3 2016 was Manulife (Manufacturers Life Insurance), an estimated $4.51M added.
  • The largest John Hancock Multifactor Healthcare ETF seller in Q3 2016 was UBS Group, an estimated $14K sold.

Based on aggregated 13F filings for Q3 2016.